(Q53068526)

11 May 2018

title

Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism. (English)

1 reference

11 May 2018

1 reference

2

1 reference

11 May 2018

Sarantos Kostidis

Sarantos Kostidis

6

0 references

Roxane Tenta

Roxane Tenta

8

0 references

Katerina Naka

Katerina Naka

5

0 references

Sofia-Iris Bibli

10

Sofia-Iris Bibli

1 reference

11 May 2018

Alexios-Leandros Skaltsounis

12

Leandros Skaltsounis

1 reference

11 May 2018

author name string

Ioanna Andreadou

1

1 reference

11 May 2018

Konstantinos Ioannidis

3

1 reference

11 May 2018

Fragiska Sigala

4

1 reference

11 May 2018

Dimitrios Farmakis

7

1 reference

11 May 2018

Nikolaos Kavantzas

9

1 reference

11 May 2018

Evangelos Gikas

11

1 reference

11 May 2018

Dimitrios Th Kremastinos

13

1 reference

11 May 2018

Efstathios K Iliodromitis

14

1 reference

11 May 2018

publication date

28 January 2014

1 reference

11 May 2018

Journal of Molecular and Cellular Cardiology

published in

1 reference

11 May 2018

volume

69

1 reference

11 May 2018

page(s)

4-16

1 reference

11 May 2018

Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Fighting doxorubicin-induced cardiotoxicity with adiponectin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Identification of Throuba Thassos, a traditional Greek table olive variety, as a nutritional rich source of oleuropein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Identification of the factors responsible for the in vitro pro-oxidant and cytotoxic activities of the olive polyphenols oleuropein and hydroxytyrosol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Liquid chromatography-tandem mass spectrometry analysis of oleuropein and its metabolite hydroxytyrosol in rat plasma and urine after oral administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Simultaneous determination of oleuropein and hydroxytyrosol in rat plasma using liquid chromatography with fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Doxorubicin pharmacokinetics--the effects of protein deprivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Erdosteine prevents doxorubicin-induced cardiotoxicity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Vascular endothelial growth factor and matrix metalloproteinase 9 expression in human carotid atherosclerotic plaques: relationship with plaque destabilization via neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

(1)H NMR-based metabonomic investigation of the effect of two different exercise sessions on the metabolic fingerprint of human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Exercise preconditioning provides long-term protection against early chronic doxorubicin cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Mitochondrials complex I activity is reduced in latent adriamycin-induced cardiomyopathy of rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracic echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Troponin-T and brain natriuretic peptide as predictors for adriamycin-induced cardiomyopathy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Thioredoxin-1 gene delivery induces heme oxygenase-1 mediated myocardial preservation after chronic infarction in hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Cardiotrophin 1 is involved in cardiac, vascular, and renal fibrosis and dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Doxorubicin induces an increase of nitric oxide synthesis in rat cardiac cells that is inhibited by iron supplementation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

The protective roles of nitric oxide and superoxide dismutase in adriamycin-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Differential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

AMP-activated protein kinase phosphorylation of endothelial NO synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Modulation of circulating endothelin-1 and big endothelin by nitric oxide inhalation following left ventricular assist device implantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Cytokines are not upregulated in adriamycin-induced cardiomyopathy and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

The impairment of essential fatty acid metabolism as a key factor in doxorubicin-induced damage in cultured rat cardiomyocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Potential biomarkers in mouse myocardium of doxorubicin-induced cardiomyopathy: a metabonomic method and its application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Amino acids as metabolic substrates during cardiac ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

More than bricks and mortar: comments on protein and amino acid metabolism in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Atrophic Remodeling of the Heart In Vivo Simultaneously Activates Pathways of Protein Synthesis and Degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.007

10.1016/J.YJMCC.2014.01.007

7 January 2021

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

24486195

1 reference

11 May 2018